EUVIMEDEUVIMED entdecken
Crossref

The combined diagnostic value of 5-hmC and PRAME immunohistochemistry in melanocytic neoplasms

Yanhong Yu, Niloufar Hosseini, David Dodington, Kimberly Wood, Danny Ghazarian, Zaid Saeed Kamil

Pathology - Research and Practice · 2025

DOI: 10.1016/j.prp.2025.155993 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathology - Research and Practice, 2025. Verfasst von Yanhong Yu und 5 weiteren Autor:innen. Beteiligte Einrichtung: University of Toronto, Toronto, ON, Canada; University Health Network, Toronto, ON, Canada. Electronic address: yanhong.yu@mail.utoronto.ca. Hauptthemen laut MEDLINE: Antigens, Neoplasm, Biomarkers, Tumor, Melanoma, Skin Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: University Health Network.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The diagnosis of melanocytic neoplasms, particularly those with borderline morphologic features, remains a challenging area in dermatopathology. 5-hydroxymethylcytosine (5-hmC) and PRAME (PReferentially expressed Antigen in MElanoma) are recent immunohistochemical markers which have been shown to be valuable in distinguishing benign from malignant melanocytic neoplasms. A retrospective cohort of 144 benign, borderline (Spitz nevi, atypical Spitz tumors and dysplastic nevi) and malignant melanocytic tumors at our institution were analyzed for 5-hmC and PRAME expression by immunohistochemistry. Compared to benign nevi, melanoma cases had higher PRAME expression (p 75 % lesional cells positive) and 5-hmC of < 0.2 was highly specific for malignancy (98 %) with a sensitivity of 61 %. Utilizing 5-hmC and PRAME in conjunction improves their diagnostic value in distinguishing benign from malignant melanocytic neoplasms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigens, NeoplasmBiomarkers, TumorMelanomaSkin Neoplasms5-MethylcytosineNevus, Epithelioid and Spindle CellDysplastic Nevus SyndromeHumansImmunohistochemistryFemaleMaleRetrospective StudiesMiddle AgedAdultAgedDiagnosis, DifferentialYoung AdultAdolescent

Stichwörter der Autor:innen

5-hydroxymethylcytosineImmunohistochemistryMelanomaNevusPReferentially expressed Antigen in MElanoma

Substanzen

PRAME protein, humanAntigens, NeoplasmBiomarkers, Tumor5-hydroxymethylcytosine5-Methylcytosine

Autor:innen und Institutionen

  • University of Toronto, Toronto, ON, Canada; University Health Network, Toronto, ON, Canada. Electronic address: yanhong.yu@mail.utoronto.ca.
  • The Ottawa Hospital, Ottawa, ON, Canada.
  • University of Toronto, Toronto, ON, Canada; University Health Network, Toronto, ON, Canada.
  • University of Saskatchewan, Regina Pasqua Hospital, Regina, SK, Canada.

Förderung

  • University Health Network

Zitieren

APA

Yu, Y., Hosseini, N., Dodington, D., Wood, K., Ghazarian, D., & Kamil, Z. S. (2025). The combined diagnostic value of 5-hmC and PRAME immunohistochemistry in melanocytic neoplasms. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2025.155993

Vancouver

Yu Y, Hosseini N, Dodington D, Wood K, Ghazarian D, Kamil ZS. The combined diagnostic value of 5-hmC and PRAME immunohistochemistry in melanocytic neoplasms. Pathology - Research and Practice. 2025. doi:10.1016/j.prp.2025.155993

BibTeX
@article{Yu2025,
  author = {Yu, Yanhong and Hosseini, Niloufar and Dodington, David and Wood, Kimberly and Ghazarian, Danny and Kamil, Zaid Saeed},
  title = {The combined diagnostic value of 5-hmC and PRAME immunohistochemistry in melanocytic neoplasms},
  journal = {Pathology - Research and Practice},
  year = {2025},
  doi = {10.1016/j.prp.2025.155993}
}
Kostenlos starten →